Victrio® DNA Immunostimulant

Victrio is indicated for in ovo administration in 18-day-old embryonated eggs as an aid in the reduction of mortality associated with Escherichia coli in embryonated eggs and newborn chicks.

Species / Premise

  • poultry


  • Escherichia coli

Product Type

  • Immunostimulant

Victrio® DNA Immunostimulant stimulates the innate immune system in poultry via a unique DNA liposome complex. The innate immune system provides a potent, rapid, nonspecific, protective response to infectious agents. Victrio works fast (24 hours) and significantly decreased post-hatch and overall mortalities under E. coli challenge1.

For in ovo administration, Victrio may be combined with Merial Inc. MAREK’S DISEASE VACCINE (HVT + SB1). Supplied in vials of 4,000 & 16,000 doses, this product supports antibiotic-free hatcheries and does not contain antibiotics or preservatives.

Victrio® DNA Immunostimulant FAQs

What are the packaging sizes for Victrio® DNA Immunostimulant?

How should Victrio® DNA Immunostimulant be prepared?

How should Victrio® DNA Immunostimulant be administered?

How should Victrio® DNA Immunostimulant be stored?

1Data on file with USDA.

Do not administer within 21 days of slaughter.

Contains no antibiotics and no preservatives.

For In Ovo Administration to 18-Day-Old Embryonated Eggs. For veterinary use only.

Victrio is based on technology developed by Juvaris BioTherapeutics and is patent protected. Animal Health applications are being exclusively developed by Bayer Animal Health and are the subject of Bayer patent applications.

Victrio® and Rethink in ovo protection are trademarks of Bayer.